Samumed
Toggle navigation
Home
About
Company
Technology
Team
Contact Us
Advisors
Patients
Pipeline
Osteoarthritis
Degenerative Disc Disease
Idiopathic Pulmonary Fibrosis
Psoriasis
Tendinopathy
Androgenetic Alopecia
Oncology
Alzheimer’s Disease
Full Pipeline
Publications
News
Careers
SAMUMED NEWS
VIEW ALL
Samumed and United Therapeutics Announce North American License Agreement for Samumed’s IPF Drug Candidate
Learn More
Samumed Closes on $438 Million in Equity Financing
Learn More
updates
×
Missed an issue? Catch up on our previous newsletters!
August 2018
July 2018
ABOUT SAMUMED
Pipeline
Publications
Company
Team
Technology
×
The Wnt Pathway
Your browser does not support HTML5 video.